Table 4.
Correlation matrix of PRO measures at baseline for all patients in the study
| FKSI-DRS | FKSI | Total FACT-G | FACT-G PWB | FACT-G SWB | FACT-G EWB | FACT-G FWB | EQ-5D index | EQ-VAS | |
| FKSI-DRS | 1.000 (291) | 0.927 (290) | 0.682 (284) | 0.844 (286) | 0.094a (288) | 0.421 (287) | 0.523 (289) | 0.655 (285) | 0.563 (286) |
| FKSI | 0.927 (290) | 1.000 (290) | 0.837 (285) | 0.852 (287) | 0.210 (289) | 0.535 (288) | 0.735 (290) | 0.685 (286) | 0.650 (287) |
| Total FACT-G | 0.682 (284) | 0.837 (285) | 1.000 (286) | 0.768 (286) | 0.527 (286) | 0.675 (285) | 0.869 (286) | 0.626 (282) | 0.612 (282) |
| FACT-G PWB | 0.844 (286) | 0.852 (287) | 0.768 (286) | 1.000 (289) | 0.093a (289) | 0.446 (285) | 0.585 (287) | 0.721 (285) | 0.591 (285) |
| FACT-G SWB | 0.094a (288) | 0.210 (289) | 0.527 (286) | 0.093a (289) | 1.000 (291) | 0.076a (287) | 0.433 (289) | 0.066a (287) | 0.184 (287) |
| FACT-G EWB | 0.421 (287) | 0.535 (288) | 0.675 (285) | 0.446 (285) | 0.076a (287) | 1.000 (289) | 0.418 (289) | 0.370 (284) | 0.288 (285) |
| FACT-G FWB | 0.523 (289) | 0.735 (290) | 0.869 (286) | 0.585 (287) | 0.433 (289) | 0.418 (289) | 1.000 (291) | 0.580 (286) | 0.619 (287) |
| EQ-5D index | 0.655 (285) | 0.685 (286) | 0.626 (282) | 0.721 (285) | 0.066a (287) | 0.370 (284) | 0.580 (286) | 1.000 (729) | 0.490 (289) |
| EQ-VAS | 0.563 (286) | 0.650 (287) | 0.612 (282) | 0.591 (285) | 0.184 (287) | 0.288 (285) | 0.619 (287) | 0.490 (289) | 1.000 (294) |
Numbers in parentheses indicate number of observations.
a
P value for all coefficients <0.002, except those marked.
PRO, patient-reported outcome; FKSI-DRS, Functional Assessment of Cancer Therapy–Kidney Symptom Index–Disease-Related Symptoms; FACT-G, Functional Assessment of Cancer Therapy-General; EQ-5D, EQ-5D self-report questionnaire; PWB, physical well-being; SWB, social well-being; EWB, emotional well-being; FWB, functional well-being.